Schrodinger (SDGR) to Release Earnings on Wednesday

Schrodinger (NASDAQ:SDGR) is expected to be releasing its Q2 2026 results after the market closes on Wednesday, August 5th. Analysts expect Schrodinger to announce earnings of ($0.4145) per share and revenue of $47.1860 million for the quarter. Parties may visit the the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Wednesday, August 5, 2026 at 4:30 PM ET.

Schrodinger (NASDAQ:SDGR) last issued its quarterly earnings data on Tuesday, May 5th. The company reported ($0.81) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.56) by ($0.25). Schrodinger had a negative return on equity of 30.85% and a negative net margin of 40.61%.The company had revenue of $58.59 million for the quarter, compared to analyst estimates of $47.57 million. During the same quarter last year, the business earned ($0.82) earnings per share. The company’s revenue was down 1.6% on a year-over-year basis. On average, analysts expect Schrodinger to post $-2 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Schrodinger Trading Up 0.9%

Schrodinger stock opened at $15.28 on Tuesday. The company has a market capitalization of $1.13 billion, a price-to-earnings ratio of -10.84 and a beta of 1.63. Schrodinger has a 12 month low of $10.94 and a 12 month high of $23.02. The stock’s 50 day moving average is $15.44 and its 200-day moving average is $13.72.

Analysts Set New Price Targets

SDGR has been the topic of a number of research reports. Wall Street Zen lowered Schrodinger from a “hold” rating to a “strong sell” rating in a report on Saturday, May 9th. Morgan Stanley dropped their target price on Schrodinger from $19.00 to $17.00 and set an “equal weight” rating for the company in a report on Thursday, May 14th. KeyCorp decreased their price target on shares of Schrodinger from $25.00 to $20.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 8th. Finally, Weiss Ratings raised shares of Schrodinger from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, July 29th. Four equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $20.25.

Institutional Trading of Schrodinger

A number of hedge funds have recently added to or reduced their stakes in the stock. Invesco Ltd. increased its holdings in shares of Schrodinger by 5.7% during the fourth quarter. Invesco Ltd. now owns 190,763 shares of the company’s stock worth $3,411,000 after buying an additional 10,307 shares in the last quarter. Susquehanna Portfolio Strategies LLC lifted its stake in shares of Schrodinger by 459.2% in the 4th quarter. Susquehanna Portfolio Strategies LLC now owns 158,162 shares of the company’s stock valued at $2,828,000 after acquiring an additional 129,877 shares during the last quarter. Tudor Investment Corp ET AL lifted its stake in shares of Schrodinger by 30.5% in the 4th quarter. Tudor Investment Corp ET AL now owns 438,925 shares of the company’s stock valued at $7,848,000 after acquiring an additional 102,546 shares during the last quarter. Perceptive Advisors LLC acquired a new stake in shares of Schrodinger during the 4th quarter valued at $3,619,000. Finally, Man Group plc boosted its holdings in shares of Schrodinger by 170.5% during the 4th quarter. Man Group plc now owns 441,363 shares of the company’s stock valued at $7,892,000 after acquiring an additional 278,189 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

About Schrodinger

Schrödinger, Inc is a life sciences and materials discovery company that specializes in the application of physics-based computational platforms to accelerate drug discovery and advanced materials design. Founded in 1990 by Professor Richard A. Friesner, Schrödinger has developed a suite of proprietary software tools—such as Maestro for molecular modeling, Glide for molecular docking and Jaguar for quantum chemistry calculations—that enable scientists to predict molecular behavior with high accuracy.